Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082–97.

Article  PubMed  Google Scholar 

Volkow ND, Blanco C. The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry. 2021;26(1):218–33.

Article  PubMed  Google Scholar 

Duarte DF. Opium and opioids: a brief history. Rev Bras Anestesiol. 2005;55(1):135–46.

PubMed  Google Scholar 

Santoro D, Bellinghieri G, Savica V. Development of the concept of pain in history. J Nephrol. 2011;24(Suppl 17):S133–6.

Article  PubMed  Google Scholar 

Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–68.

Article  PubMed  Google Scholar 

de Leon-Casasola OA. Opioids for chronic pain: new evidence, new strategies, safe prescribing. Am J Med. 2013;126(3 Suppl 1):S3-11.

Article  PubMed  Google Scholar 

Kissin I. The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth Analg. 2010;110(3):780–9.

Article  CAS  PubMed  Google Scholar 

WHO Expert Committee. The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th WHO Model List of essential Medicines for Children). WHO technical report series ; no 1006. Geneva: World Health Organization; 2017. p. 604.

Shipton EA, Shipton EE, Shipton AJ. A review of the opioid epidemic: what do we do about it? Pain Ther. 2018;7(1):23–36.

Article  PubMed  PubMed Central  Google Scholar 

Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3 Suppl):ES9-38.

Article  PubMed  Google Scholar 

Webster L, Schmidt WK. Dilemma of addiction and respiratory depression in the treatment of pain: a prototypical endomorphin as a new approach. Pain Med. 2019;21(5):992–1004.

Wang Y, Zhuang Y, DiBerto JF, Zhou XE, Schmitz GP, Yuan Q, et al. Structures of the entire human opioid receptor family. Cell. 2023;186(2):413-271e7.

Article  CAS  PubMed  Google Scholar 

Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996;383(6603):819–23.

Article  CAS  PubMed  Google Scholar 

Hsia JA, Moss J, Hewlett EL, Vaughan M. ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem. 1984;259(2):1086–90.

Article  CAS  PubMed  Google Scholar 

Taussig R, Iniguez-Lluhi JA, Gilman AG. Inhibition of adenylyl cyclase by Gi alpha. Science. 1993;261(5118):218–21.

Article  CAS  PubMed  Google Scholar 

Ippolito DL, Temkin PA, Rogalski SL, Chavkin C. N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai. J Biol Chem. 2002;277(36):32692–6.

Article  CAS  PubMed  Google Scholar 

Sadja R, Alagem N, Reuveny E. Gating of GIRK channels. Neuron. 2003;39(1):9–12.

Article  CAS  PubMed  Google Scholar 

Díaz A, Flórez J, Pazos A, Hurlé MA. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system. Pain. 2000;86(3):227–35.

Article  PubMed  Google Scholar 

Diaz A, Ruiz F, Florez J, Pazos A, Hurle MA. Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats. J Pharmacol Exp Ther. 1995;274(3):1538–44.

Article  CAS  PubMed  Google Scholar 

Wickman K, Clapham DE. Ion channel regulation by G proteins. Physiol Rev. 1995;75(4):865–85.

Article  CAS  PubMed  Google Scholar 

Dang VC, Christie MJ. Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol. 2012;165(6):1704–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Groer CE, Schmid CL, Jaeger AM, Bohn LM. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. J Biol Chem. 2011;286(36):31731–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melief EJ, Miyatake M, Bruchas MR, Chavkin C. Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A. 2010;107(25):11608–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whistler JL, Chuang H-h, Chu P, Jan LY, von Zastrow M. Functional dissociation of μ-opioid receptor signaling and endocytosis. Neuron. 1999;23(4):737–46.

Article  CAS  PubMed  Google Scholar 

Gondin AB, Halls ML, Canals M, Briddon SJ. GRK mediates mu-opioid receptor plasma membrane reorganization. Front Mol Neurosci. 2019;12:104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raffa RB, Martinez RP, Connelly CD. G-protein antisense oligodeoxyribonucleotides and μ-opioid supraspinal antinociception. Eur J Pharmacol. 1994;258(1–2):R5–7.

Article  CAS  PubMed  Google Scholar 

Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 1999;286(5449):2495–8.

Article  CAS  PubMed  Google Scholar 

Raehal KM, Walker JK, Bohn LM. Morphine side effects in β-arrestin 2 knockout mice. J Pharmacol Exp Ther. 2005;314(3):1195–201.

Article  CAS  PubMed  Google Scholar 

Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 2000;408(6813):720–3.

Article  CAS  PubMed  Google Scholar 

Gaveriaux-Ruff C, Kieffer BL. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides. 2002;36(2–3):62–71.

Article  CAS  PubMed  Google Scholar 

Yang CH, Huang HW, Chen KH, Chen YS, Sheen-Chen SM, Lin CR. Antinociceptive potentiation and attenuation of tolerance by intrathecal beta-arrestin 2 small interfering RNA in rats. Br J Anaesth. 2011;107(5):774–81.

Article  CAS  PubMed  Google Scholar 

Kliewer A, Schmiedel F, Sianati S, Bailey A, Bateman JT, Levitt ES, et al. Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects. Nat Commun. 2019;10(1):367.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bull FA, Baptista-Hon DT, Sneddon C, Wright L, Walwyn W, Hales TG. Src kinase inhibition attenuates morphine tolerance without affecting reinforcement or psychomotor stimulation. Anesthesiology. 2017;127(5):878–89.

Article  CAS  PubMed  Google Scholar 

Kliewer A, Gillis A, Hill R, Schmiedel F, Bailey C, Kelly E, et al. Morphine-induced respiratory depression is independent of beta-arrestin2 signalling. Br J Pharmacol. 2020;177(13):2923–31.